FDA Budget: Compounding Increase Paid With Construction Funding, Efficiencies
This article was originally published in The Pink Sheet Daily
Executive Summary
Some planned buildings on the White Oak campus for FY 2015 would not be funded and savings from program efficiencies would create the $25 million in new funding for compounding oversight, Hamburg tells House committee.
You may also be interested in...
Modest Increase To 2015 FDA Funds Includes $903.4 Mil. For CFSAN
An omnibus spending agreement gives FDA about a 1.3% increase from its fiscal 2014 appropriation. CFSAN’s allocation of $903.4 million represents a more than 2% increase over fiscal 2014 enacted funding, consistent with the President’s budget request and the Senate’s proposed funding, but roughly $10 million less than the original House figure.
FDA Winding Down White Oak Construction; Outside Rents Going Up
President Obama’s budget requests less headquarters consolidation funding in FY 2015 as CBER announces it will move staff to the campus between May and July.
FDA Mandates Need Accompanying Resources, Hamburg Says
The mandates in the FDA Safety and Innovation Act and Drug Quality and Security Act show a lot of congressional confidence in the agency, but FDA commissioner says that members also must provide resources to go with it.